Steven E. Nissen
Department of Cardiovascular Medicine
Cleveland Clinic Foundation
9500 Euclid Avenue
Cleveland
USA
Name/email consistency: high
- Atherosclerosis in 2010: new therapeutic insights. Nissen, S.E. Nat. Rev. Cardiol (2011)
- Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Nissen, S.E., Wolski, K. Arch. Intern. Med. (2010)
- Setting the RECORD Straight. Nissen, S.E. JAMA (2010)
- The Jupiter trial: key findings, controversies, and implications. Nissen, S.E. Curr. Cardiol. Rep (2009)
- The vulnerable plaque "hypothesis": promise, but little progress. Nissen, S.E. JACC. Cardiovasc. Imaging (2009)
- Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. Nissen, S.E., Nicholls, S.J., Wolski, K., Nesto, R., Kupfer, S., Perez, A., Jure, H., De Larochellière, R., Staniloae, C.S., Mavromatis, K., Saw, J., Hu, B., Lincoff, A.M., Tuzcu, E.M. JAMA (2008)
- Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. Nissen, S.E., Nicholls, S.J., Wolski, K., Rodés-Cabau, J., Cannon, C.P., Deanfield, J.E., Després, J.P., Kastelein, J.J., Steinhubl, S.R., Kapadia, S., Yasin, M., Ruzyllo, W., Gaudin, C., Job, B., Hu, B., Bhatt, D.L., Lincoff, A.M., Tuzcu, E.M. JAMA (2008)
- A much-anticipated FDA reform bill is signed into law: progress and compromise. Nissen, S.E. Curr. Cardiol. Rep (2008)
- Courage under fire: what is the optimal approach to initial treatment of stable angina?. Nissen, S.E. Curr. Cardiol. Rep (2008)
- A much-anticipated FDA reform bill is signed into law: progress and compromise. Nissen, S.E. Curr. Diab. Rep. (2008)
- ENHANCE and ACCORD: controversy over surrogate end points. Nissen, S.E. Curr. Cardiol. Rep (2008)
- Rationale for cardiovascular medicine to separate from internal medicine and become an independent specialty. Nissen, S.E. Curr. Cardiol. Rep (2008)
- Perspective: effect of rosiglitazone on cardiovascular outcomes. Nissen, S.E. Curr. Cardiol. Rep (2007)
- Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. Nissen, S.E., Wolski, K. N. Engl. J. Med. (2007)
- Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials. Nissen, S.E., Nicholls, S.J., Wolski, K., Howey, D.C., McErlean, E., Wang, M.D., Gomez, E.V., Russo, J.M. JAMA (2007)
- Effect of torcetrapib on the progression of coronary atherosclerosis. Nissen, S.E., Tardif, J.C., Nicholls, S.J., Revkin, J.H., Shear, C.L., Duggan, W.T., Ruzyllo, W., Bachinsky, W.B., Lasala, G.P., Lasala, G.P., Tuzcu, E.M. N. Engl. J. Med. (2007)
- Rosiglitazone: a disappointing DREAM. Nissen, S. Future. Cardiol (2007)
- Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Nissen, S.E., Nicholls, S.J., Sipahi, I., Libby, P., Raichlen, J.S., Ballantyne, C.M., Davignon, J., Erbel, R., Fruchart, J.C., Tardif, J.C., Schoenhagen, P., Crowe, T., Cain, V., Wolski, K., Goormastic, M., Tuzcu, E.M. JAMA (2006)
- Effect of ACAT inhibition on the progression of coronary atherosclerosis. Nissen, S.E., Tuzcu, E.M., Brewer, H.B., Sipahi, I., Nicholls, S.J., Ganz, P., Schoenhagen, P., Waters, D.D., Pepine, C.J., Crowe, T.D., Davidson, M.H., Deanfield, J.E., Wisniewski, L.M., Hanyok, J.J., Kassalow, L.M. N. Engl. J. Med. (2006)
- ADAPT: the wrong way to stop a clinical trial. Nissen, S.E. Plos. Clinical. Trials (2006)
- Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. Nissen, S.E., Tuzcu, E.M., Schoenhagen, P., Crowe, T., Sasiela, W.J., Tsai, J., Orazem, J., Magorien, R.D., O'Shaughnessy, C., Ganz, P. N. Engl. J. Med. (2005)
- Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Nissen, S.E. Am. J. Cardiol. (2005)
- Report from the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md. Nissen, S.E. Circulation (2005)
- Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. Nissen, S.E., Wolski, K., Topol, E.J. JAMA (2005)
- Does intensive statin therapy lower mortality and cardiovascular event risk in patients with acute coronary syndrome?. Nissen, S.E. Nature Clinical Practice. Cardiovascular Medicine (2005)
- Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Nissen, S.E. Am. J. Med. (2005)
- Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. Nissen, S.E., Tuzcu, E.M., Schoenhagen, P., Brown, B.G., Ganz, P., Vogel, R.A., Crowe, T., Howard, G., Cooper, C.J., Brodie, B., Grines, C.L., DeMaria, A.N. JAMA (2004)
- Imaging and peroxisome proliferator-activated receptor agonists: uncovering their role in atherosclerosis development. Nissen, S.E. Clin. Cardiol (2004)
- Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. Nissen, S.E., Tuzcu, E.M., Libby, P., Thompson, P.D., Ghali, M., Garza, D., Berman, L., Shi, H., Buebendorf, E., Topol, E.J. JAMA (2004)
- Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective. Nissen, S.E. J. Am. Coll. Cardiol. (2003)
- Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. Nissen, S.E., Tsunoda, T., Tuzcu, E.M., Schoenhagen, P., Cooper, C.J., Yasin, M., Eaton, G.M., Lauer, M.A., Sheldon, W.S., Grines, C.L., Halpern, S., Crowe, T., Blankenship, J.C., Kerensky, R. JAMA (2003)
- Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. Nissen, S.E. Am. J. Cardiol. (2002)
- Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Nissen, S.E., Yock, P. Circulation (2001)
- Clinical images from intravascular ultrasound: coronary disease, plaque rupture, and intervention--the inside view. Nissen, S.E. Am. J. Cardiol. (2001)
